Cargando…

Cerebral involvement in a patient with Goodpasture's disease due to shortened induction therapy: a case report

INTRODUCTION: Goodpasture's disease is a rare immunological disease with formation of pathognomonic antibodies against renal and pulmonary basement membranes. Cerebral involvement has been reported in several cases in the literature, yet the pathogenetic mechanism is not entirely clear. CASE PR...

Descripción completa

Detalles Bibliográficos
Autores principales: Preul, Christoph, Gerth, Jens, Lang, Sebastian, Bergmeier, Christoph, Witte, Otto W, Wolf, Gunter, Terborg, Christoph
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2783061/
https://www.ncbi.nlm.nih.gov/pubmed/19946538
http://dx.doi.org/10.1186/1752-1947-3-120
_version_ 1782174666535731200
author Preul, Christoph
Gerth, Jens
Lang, Sebastian
Bergmeier, Christoph
Witte, Otto W
Wolf, Gunter
Terborg, Christoph
author_facet Preul, Christoph
Gerth, Jens
Lang, Sebastian
Bergmeier, Christoph
Witte, Otto W
Wolf, Gunter
Terborg, Christoph
author_sort Preul, Christoph
collection PubMed
description INTRODUCTION: Goodpasture's disease is a rare immunological disease with formation of pathognomonic antibodies against renal and pulmonary basement membranes. Cerebral involvement has been reported in several cases in the literature, yet the pathogenetic mechanism is not entirely clear. CASE PRESENTATION: A 21-year-old Caucasian man with Goodpasture's disease and end-stage renal disease presented with two generalized seizures after a period of mild cognitive disturbance. Blood pressure and routine laboratory tests did not exceed the patient's usual values, and examination of cerebrospinal fluid was unremarkable. Cerebral magnetic resonance imaging (MRI) revealed multiple cortical and subcortical lesions on fluid-attenuated inversion recovery sequences. Since antiglomerular basement membrane antibodies were found to be positive with high titers, plasmapheresis was started. In addition, cyclophosphamide pulse therapy was given on day 13. Encephalopathy and MRI lesions disappeared during this therapy, and antiglomerular basement membrane antibodies were significantly reduced. Previous immunosuppressive therapy was performed without corticosteroids and terminated early after 3 months. The differential diagnostic considerations were cerebral vasculitis and posterior reversible encephalopathy syndrome. Vasculitis could be seen as an extrarenal manifestation of the underlying disease. Posterior reversible encephalopathy syndrome, on the other hand, can be triggered by immunosuppressive therapy and may appear without a hypertensive crisis. CONCLUSION: A combination of central nervous system symptoms with a positive antiglomerular basement membrane test in a patient with Goodpasture's disease should immediately be treated as an acute exacerbation of the disease with likely cross-reactivity of antibodies with the choroid plexus. In our patient, a discontinuous strategy of immunosuppressive therapy may have favored recurrence of Goodpasture's disease.
format Text
id pubmed-2783061
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27830612009-11-26 Cerebral involvement in a patient with Goodpasture's disease due to shortened induction therapy: a case report Preul, Christoph Gerth, Jens Lang, Sebastian Bergmeier, Christoph Witte, Otto W Wolf, Gunter Terborg, Christoph J Med Case Reports Case report INTRODUCTION: Goodpasture's disease is a rare immunological disease with formation of pathognomonic antibodies against renal and pulmonary basement membranes. Cerebral involvement has been reported in several cases in the literature, yet the pathogenetic mechanism is not entirely clear. CASE PRESENTATION: A 21-year-old Caucasian man with Goodpasture's disease and end-stage renal disease presented with two generalized seizures after a period of mild cognitive disturbance. Blood pressure and routine laboratory tests did not exceed the patient's usual values, and examination of cerebrospinal fluid was unremarkable. Cerebral magnetic resonance imaging (MRI) revealed multiple cortical and subcortical lesions on fluid-attenuated inversion recovery sequences. Since antiglomerular basement membrane antibodies were found to be positive with high titers, plasmapheresis was started. In addition, cyclophosphamide pulse therapy was given on day 13. Encephalopathy and MRI lesions disappeared during this therapy, and antiglomerular basement membrane antibodies were significantly reduced. Previous immunosuppressive therapy was performed without corticosteroids and terminated early after 3 months. The differential diagnostic considerations were cerebral vasculitis and posterior reversible encephalopathy syndrome. Vasculitis could be seen as an extrarenal manifestation of the underlying disease. Posterior reversible encephalopathy syndrome, on the other hand, can be triggered by immunosuppressive therapy and may appear without a hypertensive crisis. CONCLUSION: A combination of central nervous system symptoms with a positive antiglomerular basement membrane test in a patient with Goodpasture's disease should immediately be treated as an acute exacerbation of the disease with likely cross-reactivity of antibodies with the choroid plexus. In our patient, a discontinuous strategy of immunosuppressive therapy may have favored recurrence of Goodpasture's disease. BioMed Central 2009-11-12 /pmc/articles/PMC2783061/ /pubmed/19946538 http://dx.doi.org/10.1186/1752-1947-3-120 Text en Copyright ©2009 Preul et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case report
Preul, Christoph
Gerth, Jens
Lang, Sebastian
Bergmeier, Christoph
Witte, Otto W
Wolf, Gunter
Terborg, Christoph
Cerebral involvement in a patient with Goodpasture's disease due to shortened induction therapy: a case report
title Cerebral involvement in a patient with Goodpasture's disease due to shortened induction therapy: a case report
title_full Cerebral involvement in a patient with Goodpasture's disease due to shortened induction therapy: a case report
title_fullStr Cerebral involvement in a patient with Goodpasture's disease due to shortened induction therapy: a case report
title_full_unstemmed Cerebral involvement in a patient with Goodpasture's disease due to shortened induction therapy: a case report
title_short Cerebral involvement in a patient with Goodpasture's disease due to shortened induction therapy: a case report
title_sort cerebral involvement in a patient with goodpasture's disease due to shortened induction therapy: a case report
topic Case report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2783061/
https://www.ncbi.nlm.nih.gov/pubmed/19946538
http://dx.doi.org/10.1186/1752-1947-3-120
work_keys_str_mv AT preulchristoph cerebralinvolvementinapatientwithgoodpasturesdiseaseduetoshortenedinductiontherapyacasereport
AT gerthjens cerebralinvolvementinapatientwithgoodpasturesdiseaseduetoshortenedinductiontherapyacasereport
AT langsebastian cerebralinvolvementinapatientwithgoodpasturesdiseaseduetoshortenedinductiontherapyacasereport
AT bergmeierchristoph cerebralinvolvementinapatientwithgoodpasturesdiseaseduetoshortenedinductiontherapyacasereport
AT witteottow cerebralinvolvementinapatientwithgoodpasturesdiseaseduetoshortenedinductiontherapyacasereport
AT wolfgunter cerebralinvolvementinapatientwithgoodpasturesdiseaseduetoshortenedinductiontherapyacasereport
AT terborgchristoph cerebralinvolvementinapatientwithgoodpasturesdiseaseduetoshortenedinductiontherapyacasereport